Volume 147, Issue 4, Pages (October 2014)

Slides:



Advertisements
Similar presentations
Metformin prevents glucotoxicity by alleviating oxidative and ER stress–induced CD36 expression in pancreatic beta cells  Jun Sung Moon, Udayakumar Karunakaran,
Advertisements

Volume 35, Issue 2, Pages (April 2016)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Effect of excess iron on oxidative stress and gluconeogenesis through hepcidin during mitochondrial dysfunction  Hyo Jung Lee, Joo Sun Choi, Hye Ja Lee,
Hematopoietic Tissue Factor–Protease-Activated Receptor 2 Signaling Promotes Hepatic Inflammation and Contributes to Pathways of Gluconeogenesis and Steatosis.
Volume 11, Issue 2, Pages (April 2015)
Volume 133, Issue 2, Pages (August 2007)
Volume 132, Issue 5, Pages (May 2007)
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 20, Issue 3, Pages (July 2017)
Volume 85, Issue 3, Pages (March 2014)
Volume 19, Issue 7, Pages (July 2017)
Hui Ying Li, Yoon Sin Oh, Ji-Woong Choi, Ji Yong Jung, Hee-Sook Jun 
Volume 19, Issue 3, Pages (March 2017)
Volume 126, Issue 3, Pages (March 2004)
Volume 135, Issue 4, Pages (October 2008)
Volume 6, Issue 6, Pages (December 2007)
Volume 136, Issue 1, Pages (January 2009)
Volume 132, Issue 1, Pages (January 2007)
Volume 131, Issue 1, Pages (July 2006)
Volume 144, Issue 2, Pages (February 2013)
An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis  Laurie L. Baggio, Qingling Huang,
Volume 8, Issue 4, Pages (October 2008)
Volume 135, Issue 6, Pages e2 (December 2008)
Volume 16, Issue 10, Pages (September 2016)
Volume 137, Issue 4, Pages e5 (October 2009)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Liver Fibrosis Protects Mice From Acute Hepatocellular Injury
Volume 137, Issue 6, Pages (December 2009)
Volume 135, Issue 4, Pages (October 2008)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 142, Issue 5, Pages e1 (May 2012)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 6, Issue 3, Pages (September 2007)
Volume 11, Issue 4, Pages (April 2010)
Volume 136, Issue 4, Pages (April 2009)
Volume 134, Issue 3, Pages (March 2008)
Volume 138, Issue 1, Pages (January 2010)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 15, Issue 5, Pages (May 2012)
Volume 141, Issue 6, Pages e5 (December 2011)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 18, Issue 13, Pages (March 2017)
Volume 138, Issue 1, Pages (January 2010)
Volume 134, Issue 4, Pages (April 2008)
Volume 132, Issue 5, Pages (May 2007)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 20, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (March 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 2, Issue 5, Pages (November 2005)
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 29, Issue 5, Pages (March 2008)
Volume 135, Issue 4, Pages (October 2008)
Volume 9, Issue 5, Pages (May 2009)
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 6, Issue 1, Pages (July 2007)
Joseph T. Rodgers, Wilhelm Haas, Steven P. Gygi, Pere Puigserver 
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Prevention of Steatosis by Hepatic JNK1
Volume 9, Issue 5, Pages (May 2009)
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Volume 7, Issue 6, Pages (June 2008)
Insulin-Like Growth Factor-II Regulates the Expression of Vascular Endothelial Growth Factor by the Human Keratinocyte Cell Line HaCaT  Yoo-Wook Kwon,
Volume 7, Issue 3, Pages (March 2008)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 16, Issue 3, Pages (September 2012)
Presentation transcript:

Volume 147, Issue 4, Pages 860-869 (October 2014) Inhibition of CYP4A Reduces Hepatic Endoplasmic Reticulum Stress and Features of Diabetes in Mice  Edmond Changkyun Park, Seung Il Kim, Yeonhee Hong, Jeong Won Hwang, Gun-Sik Cho, Hye-Na Cha, Jin-Kwan Han, Chul-Ho Yun, So-Young Park, Ik-Soon Jang, Zee-Won Lee, Jong-Soon Choi, Soohyun Kim, Gun-Hwa Kim  Gastroenterology  Volume 147, Issue 4, Pages 860-869 (October 2014) DOI: 10.1053/j.gastro.2014.06.039 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 Effect of the CYP4A inhibitor HET0016 in the diabetes of db/db mice. Eight-week-old db/db mice were injected with either HET0016 (5 mg/kg/day) or dimethyl sulfoxide intraperitoneally for 2 weeks. (A) Glucose tolerance test. (B) Fasting blood glucose level. (C) Fasting serum insulin concentration. (D) Photomicrographs taken after paraffin sectioning and H&E staining of the indicated mouse liver. (E) Hepatic TG level was measured in lipid extracts from the liver tissues. (F) Malondialdehyde (MDA) formation, a measure of lipid peroxidation, was estimated by thiobarbituric acid reactive substances (TBARS) assays performed on liver tissues. Data are shown as means ± SD. P values were determined by the Student t test. *P < .05, **P < .01, and ***P < .001 for C57 vs db/db and db/db vs db/db + HET0016. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Effect of the CYP4A inhibitor HET0016 on hepatic function, ER stress, insulin resistance, and apoptosis in db/db mice. (A) Expression of gluconeogenesis (G6Pase, PEPCK, and PGC-1) and lipogenesis (DGAT2, FAS, lipin1, and SCD1) markers were examined by Western blotting in the indicated mouse liver. (B) Expression of ER stress markers, such as PERK, phospho-eIF2α, CHOP, and phospho-JNK, was monitored by Western blotting. ER-localized proteins, such as CYP4A and PERK, were analyzed from microsomal fractions of liver tissues. (C) In vivo insulin signaling was examined by investigating phosphorylation of the insulin receptor (IR) and Akt, and apoptosis was monitored by the expression of cleaved caspase-3 and caspase-9, Bax, and Bcl-2 in the liver tissues. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions

Figure 3 Effect of the CYP4A inhibitor HET0016 on diabetic pathophysiology in HFD mice. C57BL/6J mice were fed with an ND or an HFD and injected with either dimethyl sulfoxide or HET0016 (5 mg/kg/day) intraperitoneally for 12 weeks. (A) The changes in body weight of the indicated groups of mice. (B) Glucose tolerance test. (C) Insulin tolerance test. (D) Isolated liver tissues and photomicrographs taken after paraffin sectioning and H&E staining. (E) Hepatic TG level. (F) MDA formation, a measure of lipid peroxidation, was estimated by TBARS assays performed on liver tissues. Data are shown as means ± SD. P values were determined by the Student t test. *P < .05, **P < .01, and ***P < .001 for ND vs HFD and HFD vs HFD + HET0016. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions

Figure 4 Effect of the CYP4A inhibitor HET0016 on hepatic function, ER stress, insulin resistance, and apoptosis in HFD mice. (A) Expression of gluconeogenesis and lipogenesis markers in the indicated mice livers. (B) Expression of ER stress markers. ER-localized proteins, such as PERK, IRE1, and ATF6, were analyzed from microsomal fractions of liver tissues. (C) In vivo insulin signaling and apoptosis were monitored in the liver tissues. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions

Figure 5 Effect of hepatic Cyp4a knockdown on diabetes of db/db mice. Cyp4a-specific shRNA lentivirus were introduced into the liver of 8-week-old db/db mice for 2 weeks. (A) Body weight. (B) Fasting blood glucose level. (C) Glucose tolerance test. (D) Insulin tolerance test. (E) Hyperinsulinemic–euglycemic clamp. The steady-state glucose infusion rate was obtained from averaged rates of 90–120 minutes of clamp. Insulin suppression of hepatic glucose production was determined during clamp. (F) Expression of ER stress markers in the liver. ER-localized proteins, such as CYP4A and PERK, were analyzed from microsomal fractions of liver tissues. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions

Figure 6 Effect of CYP4A inhibition on ER stress in HepG2 cells. HepG2 human hepatoma cells were treated with (A) high glucose, (B) tunicamycin, or (C) thapsigargin with or without pretreatment with HET0016 or siRNAs against Cyp4a. Expression of ER stress markers was determined by Western blotting using the indicated antibodies. Gastroenterology 2014 147, 860-869DOI: (10.1053/j.gastro.2014.06.039) Copyright © 2014 AGA Institute Terms and Conditions